ScholarIQanswers from OpenAlex
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
PaperCitations, authors & open-access status
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes have?
ScholarIQcitation count
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes has 7,491 citations in the OpenAlex counts ScholarIQ stores.
When was Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes published?
ScholarIQyear
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes has 2016 year in the ScholarIQ index.
What is the open-access status of Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes?
ScholarIQoa status
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes?
ScholarIQdoi
The DOI for Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes is on the source record.
What is the PMID of Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes?
ScholarIQpmid
The PMID for Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes is on the source record.
What is the OpenAlex record for Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes?
ScholarIQopenalex
The OpenAlex for Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes is on the source record.